NCT05891782 (HAPA) is a NA clinical trial of HAPA-based Multidomain Fall Risk Management in Fall Risk, sponsored by ZHANG Qing-hua.

Who is sponsoring NCT05891782?

NCT05891782 is sponsored by ZHANG Qing-hua.

What drugs are being tested in NCT05891782?

Interventions in NCT05891782: HAPA-based Multidomain Fall Risk Management, Regular health education lectures.

Is NCT05891782 still recruiting?

NCT05891782 is currently completed. Last updated 3 March 2025.

Last reviewed 2025-03-03 · How we verify

NCT05891782: HAPA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A HAPA-based Multicomponent Fall Intervention on Older Adults With Declines in Intrinsic Capacity in Nursing Homes

Completed NA Last updated 3 March 2025

What this trial tests

NA trial testing HAPA-based Multidomain Fall Risk Management in Fall Risk in 100 participants. Completed in 30 December 2024.

Timeline

1 December 2023

Primary endpoint
20 November 2024

30 December 2024

Quick facts

Lead sponsor	ZHANG Qing-hua
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	100
Start date	1 December 2023
Primary completion	20 November 2024
Estimated completion	30 December 2024
Sites	1 location across China

Drugs / interventions tested

HAPA-based Multidomain Fall Risk Management
Regular health education lectures

Conditions studied

Fall Risk — all drugs for Fall Risk →

Sponsor

ZHANG Qing-hua

Who can join

60 and older, any sex, with Fall Risk. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Falls are a common geriatric syndrome that impedes healthy aging and are the primary cause of accidental death in older adults. Globally, more than 50% of older adults experience falls in nursing homes each year. Intrinsic capacity (IC) is a quantifiable measure of healthy aging, and consists of five dimensions: cognitive, locomotor, vitality, sensory (vision and hearing), and psychological capacity. Decline in IC is an independent factor in the occurrence of falls in older adults. A related theoretical framework indicates that healthy behaviors are the key to enhance IC. The health action process approach (HAPA) has been shown to have positive effects on health behavior promotion. Therefore, the aim of this study is to examine the effect of multidimensional fall management based on HAPA on fall risk, fall efficacy, and healthy aging among older adults with declines in IC in Chinese nursing homes.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Towards a core outcome set (COS) for intrinsic capacity (IC) intervention studies in adults in midlife and beyond: a scoping review to identify frequently used outcomes and measurement tools.
Sanchez-Rodriguez D, Bruyère O, Surquin M, Reginster JY, et al · · 2024 · cited 9× · PMID 38441748 · DOI 10.1007/s40520-023-02681-8
Effectiveness of HAPA-based multidomain fall risk management for older adults with declining intrinsic capacity in nursing homes: protocol of a randomised controlled trial.
Shang S, Cheng S, Qi L, Liu T, et al · · 2025 · PMID 40306996 · DOI 10.1136/bmjopen-2023-082702

Verify or expand the search:

Other recruiting trials for Fall Risk

Currently open trials in the same condition.

NCT06396650 — Assessment of Fall Risks and Subject-specific Training for Fall Reduction · NA · recruiting
NCT07367763 — The Relationship Between Self-Awareness and Risk of Falls During Walking in Adults · active not recruiting
NCT07108920 — Analysis of Balance Disorders After Botulinum Toxin Treatment in the Rectus Femoris in Patients With a Stiff Knee Gait · recruiting
NCT07099677 — Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk · NA · recruiting
NCT06573983 — Fall Risk Identification and Management for Older Veterans · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05891782 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by ZHANG Qing-hua
Last refreshed: 3 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05891782.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing